MeMed For Profit
The immune system is built to communicate. Our mission is to listen. We apply machine learning to translate the complex signaling of the immune system into simple, actionable diagnostic insights. MeMed�s machine learning-based diagnostics address key clinical and medical challenges in infectious diseases and inflammatory disorders. MeMed BV Bacterial and viral infections are often clinically indistinguishable
Investors
Connections from
Industry:
Biomarkers of Longevity
Investment Stage:
N/A
Technology:
Biomarker panels
Headquarters:
Tirat Carmel, Hefa, Israel
Founded Date:
2009
Investor Type:
N/A
Funding Status:
Late Stage Venture
Estimated Revenue:
$26 Million
Number Of Exists:
N/A
Employee Number:
101-250